IBD Masterclass: Choosing the Right IBD Therapy - A Patient-Clinician Connection
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Defining Success in IBD: Treat-to-Target
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Revisiting Anti-TNFs: Role, Risks, and Real-World Considerations
Michael Dolinger, MD, MBA
David T. Rubin, MD
Translating Advances into Practice: Lessons from Today’s IBD Landscape
Navigating IBD Guidelines: What Clinicians Need to Know Now
Targeting IL-23 Pathways: Evolving Biologic Strategies in IBD
Putting It All Together: A Practical IBD Treatment Selection Primer
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
Understanding the Microbiome’s Role in IBD Management
IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
Beyond Biology: Environmental and Lifestyle Influences in IBD
Treat-to-Target: Are We There Yet?
Kimberly D. Orleck, PA-C
Jennifer Geremia, PA-C
Case Review: Targets Are Met—Can You Stick the Landing?
David Rubin, MD
Diagnosing IBD: Is It IBD or Something Else? Can You Tell?
Case Review: Can You Crack This IBD Case?
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.